Related Experiment Video

Updated: May 24, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation

Romaric Lacroix1, Françoise Dignat-George

  • 1UMR 1076 Endothelium, vascular disorders and therapeutic targets, INSERM/Université Aix-Marseille, Marseille, France.

Thrombosis Research
|March 20, 2012
PubMed

Insights

Circulating microparticles (MPs) are vesicles with dual roles in blood clotting. This review explores their complex procoagulant and fibrinolytic activities, highlighting their function in maintaining hemostatic balance.

Area of Science:

  • Biochemistry
  • Hematology
  • Cell Biology

Background:

  • Circulating microparticles (MPs) are small membrane vesicles released from various cell types.
  • MPs carry receptors, mRNA, and biological activities influencing physiological functions.
  • MPs are recognized for procoagulant activity, driven by phosphatidylserine and tissue factor expression.

Purpose of the Study:

  • To present a novel perspective on microparticles as complex regulators of hemostasis.
  • To explore the ambivalent nature of MPs, encompassing both procoagulant and anticoagulant properties.
  • To highlight the role of MPs in modulating the overall hemostatic balance.

Main Methods:

  • Literature review focusing on the dual roles of circulating microparticles.
  • Analysis of studies investigating MP expression of coagulation factors and inhibitors.
  • Synthesis of current knowledge on MP contributions to fibrinolysis and hemostasis.

Main Results:

  • Microparticles exhibit both procoagulant and anticoagulant activities.
  • MPs express activators and inhibitors of the coagulation cascade.
  • MPs possess fibrinolytic properties that counteract procoagulant effects.

Conclusions:

  • Microparticles are complex structures with ambivalent roles in hemostasis.
  • MPs integrate diverse biological activities to fine-tune hemostatic balance.
  • A comprehensive understanding of MPs is crucial for comprehending hemostasis regulation.

More Related Videos

Routine Screening Method for Microparticles in Platelet Transfusions09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...